生物科技公司的每股收益超过第一季度的预期,每股收益为0.30美元,收入为7449万美元. BioStem Technologies exceeded Q1 earnings estimates with EPS of 0.30 and revenue of $74.49M.

BioStem Technologies(BSEM)报告了Q1收入,超过了预期,EPS的估计数为0.30对0.12,收入为74.49M对43.99M。 BioStem Technologies (BSEM) reported Q1 earnings, exceeding expectations with EPS of 0.30 vs. 0.12 estimate and revenue of $74.49M vs. $43.99M estimate. 公告发布后，股价上涨0.50美元至12.50美元，成交量为65,600股，而平均成交量为25,206股。 Following the announcement, shares increased by 0.50 to $12.50 on a volume of 65,600 shares, compared to the average of 25,206. 生命科学公司侧重于制药和再生医药产品和服务。 The life sciences company focuses on pharmaceutical and regenerative medicine products and services.

文章

The Enterprise Leader

Daily Political

WKRB 13

-- 显示更少 --

延伸阅读

相关故事